SIG
ZBH icon

Stanford Investment Group’s Zimmer Biomet ZBH Stock Holding History

Stanford Investment Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-60
Closed -$8K – 415
2016
Q3 		$8K Buy
+60
New +$7.41K ﹤0.01% 342

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Stanford Investment Group's ZBH Position: Q4 2016 in Review

Stanford Investment Group sold out of Zimmer Biomet (ZBH) in Q4 2016, closing a stake of 60 shares — an estimated $8K sold.

Stanford Investment Group first reported a position in ZBH in Q3 2016 and held it in 1 quarter. The position peaked at $8K in Q3 2016. 813 funds tracked by Wall St. Rank hold ZBH as of Q4 2016.

  • Stanford Investment Group reported no remaining Zimmer Biomet position as of Q4 2016 after selling out during the quarter.
  • Stanford Investment Group sold 60 Zimmer Biomet shares in Q4 2016, an estimated $8K.
  • Stanford Investment Group first reported a position in Zimmer Biomet in Q3 2016 and held it in 1 quarter.
  • Stanford Investment Group's Zimmer Biomet position peaked at $8K in Q3 2016.
  • 813 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2016.

Based on Stanford Investment Group's 13F filing for Q4 2016, filed 2 Feb 2017.